Full-On Reversal of Cardiac Amyloidosis Possible With Antibodies
It is possible for transthyretin amyloid cardiomyopathy (ATTR-CM, also called cardiac ATTR amyloidosis) to be reversed with antibody treatment, as suggested by rare cases of patients who had their ATTR-related heart failure resolve spontaneously, with cardiac structure and function restored to almost normal. In a small case series, three men (ages 68, 82, and 76) […]